Shots: Gaeta to receive $0.2M up front and is eligible to receive ~$7.5M in clinical and regulatory milestones based on product and indication The agreement will expand Oncorus’ clinical development […]readmore
Tags : Immune Checkpoint Inhibitors
Event description: Our 4th Annual MarketsandMarkets Next Gen Immuno-Oncology Virtual Congress-US Edition to be held on 28th June – 1st July 2021 would address the challenges and future directions in […]readmore